A volumetric analysis of timing and duration of T2/FLAIR changes on MRI following radiation therapy in patients with low-grade IDH-mutant glioma [0.03%]
IDH突变型低级别胶质瘤放疗后T2/FLAIR改变的时间及持续时间的立体分析
Isabella Sutherland,Adam Ulano,Alissa A Thomas
Isabella Sutherland
Background: Patients with IDH-mutant low-grade glioma (LGG) can achieve many years of survival with radiation (RT) and chemotherapy. There is a risk of overtreatment and negative treatment side effects if these patients a...
Just a bit outside: An attempt to improve overlooked symptoms and how this may be accomplished [0.03%]
略显边缘：提高被忽视症状的关注度及其方法探讨
Patrick Regis,Megan Kranz,Robert Cavaliere
Patrick Regis
Severe temozolomide-induced thrombocytopenia is linked to increased healthcare utilization in glioblastoma and disproportionally impacts female patients [0.03%]
替莫唑胺所致严重血小板减少症与胶质母细胞瘤患者医疗利用率增加有关且女性患者受影响更大
Leon van Hout,Alessia D Borgo,Nienke Grun et al.
Leon van Hout et al.
Background: Thrombocytopenia is a major temozolomide-induced adverse event during the standard treatment of glioblastoma. Consequently, platelet transfusions and treatment modifications may impact quality of life and long...
Causal assessments of multilevel social determinant factors on meningioma disparities in the United States [0.03%]
美国多级社会决定因素对脑膜瘤差异的因果评估
David J Fei-Zhang,Rishabh Sethia,Larry W Wang et al.
David J Fei-Zhang et al.
Background: Prior investigations into meningioma disparities have explored associative relationships of socioeconomic status (SES) and race-ethnicity but face gaps in the range of other social determinants/drivers of heal...
Histopathologically confirmed radiation necrosis: Risk factors and clinical outcomes in patients with primary brain tumors [0.03%]
放射性脑坏死的危险因素及预后研究——以原发性脑肿瘤为例
Mohammad Hazaymeh,Vesna Malinova,Lidia Stork et al.
Mohammad Hazaymeh et al.
Background: Radiation necrosis is a recognized complication following radiotherapy for primary brain tumors, presenting diagnostic and therapeutic challenges, and potentially masquerading as tumor recurrence. This study a...
Evaluating liquid biopsy biomarkers for early detection of brain metastasis: A systematic review [0.03%]
系统评价液体活检生物标志物在早期脑转移检测中的应用价值
Jinyue Yu,Craig Paterson,Phillippa Davies et al.
Jinyue Yu et al.
Background: Brain metastases (BMs) are the most common intracranial malignancy in adults, contributing significantly to cancer-related morbidity and mortality. Early detection is critical for optimizing treatment and impr...
Survival, quality of life, and motor function in brain metastases surgery: The role of complete resection [0.03%]
脑转移瘤手术中的生存率、生活质量及运动功能与全切的关系研究
Rebecca R Winther,Marianne J Hjermstad,Olav Erich Yri et al.
Rebecca R Winther et al.
Background: One in 3 patients with advanced cancer develops brain metastases. Surgical resection of brain metastases is done in 15%-20% of these patients. While gross total resection (GTR) is believed to extend overall su...
Screening for brain metastases in patients with advanced non-small cell lung cancer and an actionable genomic alteration: A structured literature review [0.03%]
针对非小细胞肺癌伴潜在可操作基因组改变患者的脑转移筛查：结构化文献回顾
Jarno W J Huijs,Martina Bortolot,Anna S Berghoff et al.
Jarno W J Huijs et al.
Background: Brain metastases (BM) frequently occur in patients with non-small cell lung cancer (NSCLC) with actionable genomic alterations (AGA). Targeted therapies (TTs) improve outcomes, but differences in BM screening ...
Operative performance of RAPNO DIPG imaging criteria-a study from the International DIPG/DMG Registry [0.03%]
RAPNO DIPG影像标准的临床表现研究——来自国际DIPG / DMG登记处的研究
Hamza S Gorsi,Melike Guryildirim,Michael Kuwabara et al.
Hamza S Gorsi et al.
Background: The Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group for diffuse intrinsic pontine glioma (DIPG) recently published its recommendations. We aim to test the operative performance of the RAP...
Measures of physical functioning in adults with brain tumor associated with functional outcomes: A scoping review [0.03%]
脑肿瘤成人患者的体能评价指标与功能结局的关联性：系统综述
Tara S Davis,Emory Hsieh,Bennett A McIver et al.
Tara S Davis et al.
Neuro-oncology researchers and clinicians rely mostly on subjective measures to evaluate physical functioning (PF) and predict survival in primary brain tumor (PBT) patients. Exploring alternative clinical outcome assessment (COA) measures ...